Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors.

How Direct Digital Investing can pave the way to the Stock Market

Biotech venture capital roundup: Osanni Bio leads with $190M Series B

A roundup of recent venture capital financings in the biotech sector, headlined by Osanni Bio's $190 million Series B round to fund drug can

Not Found

Germany’s Merck Pumps Up Life Sciences Biz with $11.3B Bio-Techne Deal

STAT+: A year after distressed buyout, what’s become of Bluebird Bio?

Biotech NRx to sell new shares to fund growth and operations